<p>The hypothalamus plays a central role in regulating energy balance, and its dysfunction is a key contributor to the development of metabolic diseases such as obesity and type 2 diabetes. Although peripheral inflammation has been extensively studied, hypothalamic inflammation, termed hypothalamic microinflammation, has emerged as a critical early event in the pathogenesis of these diseases. This localized, moderate, yet sustained inflammatory response involves a complex interplay between different cell types, including microglia, astrocytes, neurons, and tanycytes, which exhibit temporal and dynamic changes. Hypothalamic microinflammation is triggered by various metabolic stressors, including high-fat diets, aging, and glial priming, and occurs even before peripheral tissues show signs of inflammation. In this review, we propose a conceptual framework that divides the progression of hypothalamic microinflammation into three distinct phases: the Initiation Spark, characterized by rapid inflammatory signaling; the Adaptive Transition, where compensatory mechanisms attempt to restore homeostasis; and the Dysfunctional Phase, leading to chronic inflammation and metabolic dysfunction. Despite significant progress in understanding hypothalamic inflammation, several critical questions remain, including the precise triggers of this response, the chronology of molecular and cellular events, and the reversibility of early changes. Additionally, emerging evidence suggests that sex differences influence the susceptibility and progression of hypothalamic microinflammation, further complicating our understanding. This review examines the dynamics of hypothalamic microinflammation, its impact on brain and peripheral insulin resistance, and its role in disrupting energy balance. Understanding these processes is crucial for identifying therapeutic targets and early intervention windows to prevent or reverse metabolic diseases.</p>